Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from IVD Medical Holding Limited ( (HK:1931) ).
ETHK Labs Inc. has appointed 32-year-old medical scientist Yi Xiao as an executive director and chief scientist, effective 6 February 2026, bolstering its leadership with a strong profile in obstetrics, gynaecology and translational medicine. Yi holds medical degrees from the University of South China and Southern Medical University, serves as a professor at Zhujiang Hospital’s Translational Medicine Centre, and holds multiple roles in leading medical and biomedical associations, while having led nationally funded research projects that contributed to products achieving IND approval and Class III medical device registration. Her appointment underscores the company’s emphasis on R&D and innovation in reproductive and regenerative medicine, and she will serve on the board until the 2026 annual general meeting under a service agreement that provides HK$30,000 in monthly director’s remuneration plus potential bonuses and benefits, aligning her compensation with market practice and her responsibilities.
The most recent analyst rating on (HK:1931) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on IVD Medical Holding Limited stock, see the HK:1931 Stock Forecast page.
More about IVD Medical Holding Limited
ETHK Labs Inc. is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange. Through its group of subsidiaries, it operates in the biomedical and medical technology sector, focusing on advanced clinical and translational medicine solutions, including products that have obtained investigational new drug approvals and Class III medical device registrations, positioning it within high-end, innovation-driven healthcare markets.
Average Trading Volume: 3,898,399
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.11B
For detailed information about 1931 stock, go to TipRanks’ Stock Analysis page.